Stage I Diagnostics, Inc.
Biotechnology company · Little Rock, Arkansas, United States
Stage I Diagnostics, Inc. is a biotechnology company headquartered in Little Rock, Arkansas, United States. Its earliest recorded incorporation is in 2005. It has reported private securities offerings to the US SEC, most recently $101,250 sold in a notice filed in 2018.
Stage I Diagnostics at a glance
What does Stage I Diagnostics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $101,250 sold (2018).
Frequently asked questions about Stage I Diagnostics
Where is Stage I Diagnostics headquartered?
Stage I Diagnostics, Inc. is headquartered in Little Rock, Arkansas, United States.
What does Stage I Diagnostics do?
Stage I Diagnostics, Inc. is a biotechnology company.
When was Stage I Diagnostics founded?
The earliest incorporation on record for Stage I Diagnostics, Inc. is in 2005, according to public company registers.
Similar companies
- NuShores Biosciences LLCLittle Rock, Arkansas, United States
- CytoAstra, LLCLittle Rock, Arkansas, United States
- Intervexion Therapeutics, LLCLittle Rock, Arkansas, United States
- Synactix Pharmaceuticals, Inc.Little Rock, Arkansas, United States
- Apothewell, Inc.Little Rock, Arkansas, United States
- Respiderm CorpLittle Rock, Arkansas, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences